Pediatric Rheumatology

Article	Citations
Predictive model based on gene and laboratory data for intravenous immunoglobulin resistance in Kawasaki disease in a Chinese population	172
Predictors of fibrogenesis in children with JIA: a single-center pilot study	44
Musculoskeletal symptoms and their impact on health-related quality of life in chronic nonbacterial osteomyelitis patients	43
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial	41
Algorithmic approach in the diagnosis of pediatric uveitis	37
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis	37
Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study	29
The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource	28
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives	26
Experiences of sexual and reproductive health screening and counseling in the clinical setting among adolescents and young adults with rheumatic disease	24
Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus	22
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience	22
Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)	22
Developmentally appropriate transitional care during the Covid-19 pandemic for young people with juvenile-onset rheumatic and musculoskeletal diseases: the rationale for a position statement	20
Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators	20
Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study	20
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis	20
Proceedings of the 29th European Paediatric Rheumatology Congress	19
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis	19
Therapeutic recreation camps for youth with childhood-onset systemic lupus erythematosus: perceived psychosocial benefits	19
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (S	18
Natural autoimmunity in oligoarticular juvenile idiopathic arthritis	18
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study	18
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study	17
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication	17

A randomized controlled educational study to evaluate an e-learning module to teach the physical examination of the temporomandibular joint in juvenile idiopathic arthritis	17
Relationship of regional ultraviolet index data with rash and systemic disease activity in youth with childhood-onset systemic lupus: results from the Childhood Arthritis and Rheumatology Research All	17
Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center	16
Clinical and genetic characteristics of PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome	16
Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals	16
The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients	16
Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis	15
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge	15
Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort	15
Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, and autoimmune diseases in a pediatric population: a comprehensive analysis	15
Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis	14
Translating research into practice—implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retr	14
Correction: PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	14
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis	13
14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report	13
Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry	13
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice	13
How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience	13
Exploring paediatric rheumatology care: a ten-year retrospective analysis of the patient population in Ghana	13
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study	13
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report	12
Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study	12
Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: a case control study	12
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis	12
Long noncoding RNAs (CTC-471J1.2, NeST) as epigenetic risk factors of active juvenile lupus nephritis: a case-control study	12
Feasibility of quantitative sensory testing in juvenile idiopathic arthritis	12
Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature	12
COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?	12
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis	11
The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study	11
Tapering of biological treatment in autoinflammatory diseases: a scoping review	11
NLRP12-associated systemic autoinflammatory diseases in children	11
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya	11
Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report	11
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review	11
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort	11
Differences between leukemic arthritis and juvenile idiopathic arthritis	11
Exploring the clinical profiles and management of juvenile dermatomyositis in Africa: a survey of African rheumatology care providers	11
Frequency of Fabry disease in a juvenile idiopathic arthritis cohort	11
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis	11
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases	11
Screening for celiac disease in juvenile idiopathic arthritis	11
A virtual pediatric rheumatology teaching initiative for physicians in Somaliland	10
The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertia	10
Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies	10
Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review	10
A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptoms patient	10
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms	10
Epstein–Barr Virus encephalitis associated hemophagocytic lymphohistiocytosis in childhood-onset systemic lupus erythematosus: a case-based review	10
Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis	10

Kawasaki disease in Kenya and review of the African literature	10
Monogenic disorders as mimics of juvenile idiopathic arthritis	10
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis	10
Hypertension as a prominent manifestation secondary to renal artery lesions in pediatric Behcet’s disease	10
Structural ultrasound of joints and tendons in healthy children: development of normative data	9
Chronic non-bacterial osteomyelitis in children- five-year standardized follow-up of a prospective observational cohort in the pre-biological era	9
Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain	9
Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud’s phenomenon	9
A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences	9
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients	9
Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility	9
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases	9
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance	9
Correction: Transition readiness among finnish adolescents with juvenile idiopathic arthritis	9
Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis	9
Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids	8
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong	8
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research	8
Transition readiness in adolescents and young adults with chronic rheumatic disease in Oman: today’s needs and future challenges	8
Comment on: homozygous variant p. Arg90His in NCF1 is associated with early-onset interferonopathy: a case report	8
Assay for interferon gamma release as a novel marker in pediatric patients with systemic lupus erythematosus	8
Axial involvement in enthesitis-related arthritis: results from a single-center cohort	8
MicroRNA-27a-3p enhances the inflammatory phenotype of Juvenile Idiopathic Arthritis fibroblast-like synoviocytes	8
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination	8
Scurvy masquerading as IgA vasculitis	8
Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor	8
Depression and anxiety in childhood-onset systemic lupus erythematosus: prevalence, associated factors, and impact on quality of life and family	8
Bone health and physical activity in adolescents with juvenile idiopathic arthritis: a cross-sectional case-control study	8
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data	8
Characterizing lupus in African American children in Southern United States	8
Towards a histological diagnosis of childhood small vessel CNS vasculitis	8
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study	8
Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis	8
Is an association of acro-osteolysis, bone fragility, and enchondromatosis a newfound disease caused by an amplification of PTHLH? A case report	7
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors	7
ANCA-negative eosinophilic granulomatosis with polyangiitis in a girl misdiagnosed as asthma and pulmonary tuberculosis	7
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe	7
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series	7
Kawasaki disease with an asymptomatic reversible splenial lesion	7
Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	7
Panniculitis with late onset enthesitis-related arthritis: a case report	7
Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report	7
Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study	7
What have we learned from long-term studies in juvenile idiopathic arthritis? – Prediction, classification, transition.	7
Juvenile idiopathic arthritis in Jordan: single center experience	7
Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain	7
Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia	7
Correction: Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases	7
Paediatric autoimmune diseases with ELANE mutations associated with neutropenia	7
Unveiling the uncommon: diagnostic journey of camurati-engelmann disease in a pediatric patient	7
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE	7
Novel multiple Z-score models for detection of coronary artery dilation: application in Kawasaki disease	6
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study	6
Nailfold videocapillaroscopy in patients with deficiency of adenosine deaminase 2 (DADA2): a case-control study	6
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis	6
Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature	6
Prevalence of spine pain among Tunisian children and adolescents and related factors	6
Bacterial infection in patients with juvenile systemic lupus erythematosus and fever	6
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry	6
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	6
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study	6
Blau syndrome: a case report from Palestine	6
Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease	6
An updated overview of Juvenile systemic sclerosis in a French cohort	6
“I’d like more options!”: Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis	6
Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial	6
Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study	6
Accuracy and adequacy of photoprotection in pediatric systemic lupus erythematosus patients, and the effect of education on photoprotection: a prospective study	6
Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study	6
Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study	6
Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry	6
Effect of exercise training on heath, quality of life, exercise capacity in juvenile idiopathic arthritis: a meta-analysis of randomized controlled trials	6
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort	6
PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	6
Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis	5
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA	5
The relationships of kinesiophobia and physical function and physical activity level in juvenile idiopathic arthritis	5
Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study	5
The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?	5
Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study	5

Serine, N-acetylaspartate differentiate adolescents with juvenile idiopathic arthritis compared with healthy controls: a metabolomics cross-sectional study	5
Proceedings of the 2024 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting	5
Juvenile diabetes and systemic sclerosis: just a coincidence?	5
Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach	5
Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment	5
Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype	5
Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis	5
The effect of TNF treatment uptake on incident hospital admission in Western Australia	5
Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)	5
Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus	5
The use of ECMO in pediatric granulomatosis with polyangiitis	5
Correction: Engaging patients and parents to improve mental health intervention for youth with rheumatological disease	5
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children wit	5
Favorable outcomes with reduced steroid use in juvenile dermatomyositis	5
Development and validation of the Sorting non-trauMatIc adoLescent knEe pain (SMILE) tool – a development and initial validation study	5
Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity	5
Economic impact of Juvenile Idiopathic Arthritis: a systematic review	5
Quality improvement in juvenile idiopathic arthritis: a mixed-methods implementation pilot of the CAPTURE-JIA dataset	5
International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders	5
A mixed-method systematic review evaluating interventions in paediatric rheumatology to address caregiver support and well-being	5
Kawasaki disease in neonates: a case report and literature review	5
A case report of a severe neonatal systemic vasculitis on the first day of life	5
Publisher Correction: Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	5
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis	5
Synchronous disease onset and flares in siblings with PFAPA	5
Biologic medicine inclusion in 138 national essential medicines lists	5
A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report	5
Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic	4
The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study	4
Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment	4
Correction: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	4
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients	4
Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East	4
Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	4
Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report	4
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients	4
“Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still’s disease.”	4
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series	4
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset	4
Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period	4
Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease	4
Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review	4
Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata	4
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up	4
Juvenile eosinophilic fasciitis: a single center case series	4
Reverse complete heart block using transcutaneous pacing and repeated plasmapheresis in a neonate with lupus: a case report	4
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis	4
Revising the WHO Essential Medicines List for paediatric rheumatology update	4
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	4
Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study	4
Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study	4
Clinical features of Kawasaki disease initially mimicking retropharyngeal abscess: a retrospective analysis	4
Clinical observations on infliximab treatment of infantile onset Takayasu arteritis	4
Perspectives and experiences of parents of children with juvenile dermatomyositis: a semi-structured interview study	4
Kawasaki disease complicated by peripheral artery thrombosis: a case report and literature review	4
Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry	4
Intravenous administration of anakinra in children with macrophage activation syndrome	4
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates	4
A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice	4
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list	4
Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients	4
Longitudinal follow-up of mixed connective tissue disease and overlapping autoimmune diseases of childhood onset in the Afro-descendant population of the French West Indies	4
Increasing and maintaining rates of standardized depression screening in youth with childhood-onset systemic lupus erythematosus in a pediatric rheumatology clinic	3
Intra-articular venous malformations of the knee: a diagnostic challenge	3
Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus	3
A mixed methods evaluation of the Paediatric Musculoskeletal Matters (PMM) online portfolio	3
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans	3
Retropharyngeal abscess-like as an atypical presentation of Kawasaki disease: a case report and literature review	3
Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study	3
Targeted provider education and pre-visit planning increase rates of formal depression screening in childhood-onset SLE	3
Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus	3
Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials	3
Juvenile idiopathic recurrent parotitis (JIRP) treated with short course steroids, a case series study and one decade follow up for potential autoimmune disorder	3
Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients	3
Primary antiphospholipid syndrome in pediatrics: beyond thrombosis. Report of 32 cases and review of the evidence	3
Shaping the future of pediatric rheumatology	3
Evidence of persistent glial cell dysfunction in the anterior cingulate cortex of juvenile idiopathic arthritis children: a proton MRS study	3
Development and validation of the RACER (Readiness for Adult Care in Rheumatology) transition instrument in youth with juvenile idiopathic arthritis	3
Correction to: Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	3
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy	3
Resilience and its associations in children with Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis	3
Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report	3
Pulmonary manifestations of childhood-onset primary Sjogren’s syndrome (SS) masquerading as reactive airways disease in a male patient and review of interstitial lung disease associated with SS	3
Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices	3
Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva	3
Lack of HLH in FMF	3
Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study	3
Significance of differential diagnosis for the elucidation of rare and complicated diseases	3
Antibodies to histone in the pediatric population: a retrospective chart review	3
A case of dermatomyositis in a patient with central core disease: unusual association with autoimmunity and genetic muscle disease	3
Cardiac repolarization abnormalities in children with familial Mediterranean fever	3
Clinical characteristics and risk factors of coronary artery lesions in chinese pediatric Takayasu arteritis patients: a retrospective study	3
Bridging gaps: a qualitative inquiry on improving paediatric rheumatology care among healthcare workers in Kenya	3
Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience	3
Identifying circRNA-associated-ceRNA networks in juvenile spondyloarthropathies patients	3